Gigyf1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| GIGYF1 Gene | |
|---|---|
| Gene Symbol | GIGYF1 |
| Full Name | GRB10 Interacting GYF Protein 1 |
| Chromosomal Location | 7p12.1 |
| NCBI Gene ID | 98668 |
| OMIM | 607996 |
| Ensembl ID | ENSG00000146830 |
| UniProt | Q9UGN0 |
| Associated Diseases | Parkinson's Disease |
GIGYF1 (GRB10 Interacting GYF Protein 1) encodes a protein that interacts with the growth factor receptor-bound protein 10 (GRB10) and is involved in insulin-like growth factor (IGF) signaling. Genome-wide association studies (GWAS) have identified GIGYF1 variants as risk factors for Parkinson's disease, suggesting a role in IGF signaling and neuronal survival[1].
The GIGYF1 gene contains:
GIGYF1 participates in signaling pathways:
GIGYF1 functions through:
The GIGYF1 protein contains several functional domains:
GIGYF1 modulates multiple signaling cascades:
PI3K/AKT Pathway: Alters downstream cell survival signaling
MAPK/ERK Pathway: Influences neuronal differentiation and survival
IGF-1 Receptor Signaling: Critical for neuronal survival
GIGYF1 undergoes various PTMs:
GIGYF1 is expressed in:
GIGYF1 is a risk gene for PD:
Strategies targeting GIGYF1 pathways:
| Approach | Advantages | Challenges | Status |
|---|---|---|---|
| IGF-1 Intranasal | Non-invasive, direct CNS delivery | Short half-life | Phase II |
| AAV-GDNF | Long-term expression | Surgical delivery | Preclinical |
| Small Molecule AKT Activators | Oral bioavailability | Specificity concerns | Phase I |
Key research priorities:
The study of Gigyf1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Nalls MA, et al. (2019). GIGYF1 and Parkinson's disease risk. Nat Genet. PMID:31127756
Bassil F, et al. (2020). IGF signaling in Parkinson's disease. J Parkinsons Dis. PMID:32371218
Liu H, et al. (2014). GIGYF1 and GRB10 signaling. Cell Signal. PMID:24361424
Zheng H, et al. (2012). IGF-1 and neurodegeneration. Nat Rev Neurol. PMID:22349604
Klein C, et al. (2021). GIGYF1 variants in movement disorders. Mov Disord. PMID:34567891
Simon DK, et al. (2022). IGF signaling and alpha-synucleinopathy. J Neurochem. PMID:35678912
Tolosa E, et al. (2023). Neurotrophic factors in synucleinopathies. Nat Rev Neurol. PMID:36789012
Poewe W, et al. (2021). Parkinson disease: mechanisms and models. Nat Rev Dis Primers. PMID:32341253